(Q34581503)

3 August 2017

1 reference

title

Recent developments in carbapenems (English)

1 reference

3 August 2017

main subject

carbapenem antibiotic

0 references

author name string

Giovanni Bonfiglio

series ordinal

1

1 reference

3 August 2017

Giovanni Russo

series ordinal

2

1 reference

3 August 2017

Giuseppe Nicoletti

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Expert Opinion on Investigational Drugs

3 August 2017

published in

1 reference

3 August 2017

volume

11

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

529-544

1 reference

Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Imipenem: first of a new class of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Radiolabeled quaternary carbapenems and their interactions with human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

In vitro activity of BMS-181139, a new carbapenem with potent antipseudomonal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Binding of Thienamycin and Clavulanic Acid to the Penicillin-Binding Proteins of Escherichia coli K-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Escherichia coli resistance to β-lactam antibiotics through a decrease in the affinity of a target for lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Antibacterial properties of BO-2727, a new carbapenem antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Imipenem as substrate and inhibitor of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Interactions of biapenem with active-site serine and metallo-beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

A functional classification scheme for beta-lactamases and its correlation with molecular structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

The structure of β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

The production and molecular properties of the zinc beta-lactamase of Pseudomonas maltophilia IID 1275.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Purification and characterization of inducible beta-lactamases in Aeromonas spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Biochemical properties of beta-lactamase produced by Legionella gormanii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Biochemical properties of beta-lactamase produced by Flavobacterium odoratum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Metallo-beta-lactamase producers in environmental microbiota: new molecular class B enzyme in Janthinobacterium lividum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Appearance of IMP-1 metallo-beta-lactamase in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Standard numbering scheme for class B beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Role of OmpD2 and chromosomal β-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

In vitro antibacterial activity and beta-lactamase stability of a new carbapenem, BO-2727.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Mechanism of enhanced antipseudomonal activity of BO-2727, a new injectable 1-beta-methyl carbapenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

The in-vitro activity of L-627 against anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Selecting therapy for serious infections in children: maximizing safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.529

PS-8, a minor carbapenem antibiotic

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.35.763

A novel beta-lactamase inhibitor, SF-2103 A produced by a Streptomyces

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.35.533

Olivanic acids, a family of .BETA.-lactam antibiotics with .BETA.-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.32.295

Carpetimycins A and B, new beta-lactam antibiotics

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.33.1388

PS-6 and PS-7, new beta-lactam antibiotics. Isolation, physicochemical properties and structures.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.33.1128

Identifiers

DOI

10.1517/13543784.11.4.529

1 reference

3 August 2017

1 reference